Civil Litigation
Sep. 26, 2017
Plaintiff’s expert testifies about potential risk of coffee
A plaintiff’s epidemiologist witness testified in the Starbucks product labeling trial Monday that some studies show drinking coffee poses a cancer risk, though he could not speak to a causal relationship.
LOS ANGELES — A plaintiff’s epidemiologist witness testified in the Starbucks product labeling trial Monday that some studies show drinking coffee poses a cancer risk, though he could not speak to a causal relationship.
The Council on Education and Research on Toxics is suing more than 65 coffee retailers, roasters and stores for selling coffee without a warning stating the presence of acrylamide in coffee is linked to cancer. They ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In